Skip to Main Content

Author Details

Mara Gilardi
Institute of Medical Genetics and Pathology.
2014
29
16
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35926164Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.Am J Respir Crit Care Med2023
37188201Tumor heterogeneity: preclinical models, emerging technologies, and future applications.Front Oncol2023
36721025Differential angiogenesis of bone and muscle endothelium in aging and inflammatory processes.Commun Biol2023
35086958Microneedle-mediated Intratumoral Delivery of Anti-CTLA-4 Promotes cDC1-dependent Eradication of Oral Squamous Cell Carcinoma with Limited irAEs.Mol Cancer Ther2022
35393541Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities.Nat Rev Cancer2022
34971567B cells secrete GABA, which provokes a pro-tumor immune microenvironment.Cancer Cell2022
34333365The driving role of the Cdk5/Tln1/FAK<sup>S732</sup> axis in cancer cell extravasation dissected by human vascularized microfluidic models.Biomaterials2021
33687407Correction: A microphysiological early metastatic niche on a chip reveals how heterotypic cell interactions and inhibition of integrin subunit β<sub>3</sub> impact breast cancer cell extravasation.Lab Chip2021
33522559A microphysiological early metastatic niche on a chip reveals how heterotypic cell interactions and inhibition of integrin subunit β<sub>3</sub> impact breast cancer cell extravasation.Lab Chip2021
33735854Engineering the early bone metastatic niche through human vascularized immuno bone minitissues.Biofabrication2021
33888713Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer.Nat Commun2021
34725466EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1.Commun Biol2021
32127469Anti-KIT DNA Aptamer for Targeted Labeling of Gastrointestinal Stromal Tumor.Mol Cancer Ther2020
32848210HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers.Oncogene2020
32727882Tipifarnib as a Precision Therapy for <i>HRAS</i>-Mutant Head and Neck Squamous Cell Carcinomas.Mol Cancer Ther2020
32304937Redirecting extracellular proteases to molecularly guide radiosensitizing drugs to tumors.Biomaterials2020
32205868Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK-YAP signaling axis.Oncogene2020
308943724E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer.Cancer Res2019
31804466Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4.Nat Commun2019
29518415Tackling muscle fibrosis: From molecular mechanisms to next generation engineered models to predict drug delivery.Adv Drug Deliv Rev2018
30590054Engineering an Environment for the Study of Fibrosis: A 3D Human Muscle Model with Endothelium Specificity and Endomysium.Cell Rep2018
28589446Bioprinting and Organ-on-Chip Applications Towards Personalized Medicine for Bone Diseases.Stem Cell Rev Rep2017
27078586A 3D vascularized bone remodeling model combining osteoblasts and osteoclasts in a CaP nanoparticle-enriched matrix.Nanomedicine (Lond)2016
26524536Human in vitro 3D co-culture model to engineer vascularized bone-mimicking tissues combining computational tools and statistical experimental approach.Biomaterials2016
27161700PO-12 - The key role of talin-1 in cancer cell extravasation dissected through human vascularized 3D microfluidic model.Thromb Res2016
27571063In Vitro Co-Culture Models of Breast Cancer Metastatic Progression towards Bone.Int J Mol Sci2016
27571058Cardiac Meets Skeletal: What's New in Microfluidic Models for Muscle Tissue Engineering.Molecules2016
25524628Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation.Proc Natl Acad Sci U S A2015
25335447Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases.Mol Cancer2014
  • 1 - 29 of 29

Recommended Authors

Shelly Kaushik
Invictus Oncology Pvt. Ltd.
Career Start Year 2014
Number of shared co-authors 0
Kien Pham
Yale School of Public Health
Career Start Year 2012
Number of shared co-authors 0
Filip Roudnicky
F. Hoffmann-La Roche Ltd.
Career Start Year 2012
Number of shared co-authors 0
Daniel J McGrail
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year 2012
Number of shared co-authors 0
Paola A Guerrero
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Minhyung Kim
Roswell Park Comprehensive Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Fabrice Lucien
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 0
Chad V Pecot
University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 0
Giorgio Seano
Institut Curie, INSERM U1, CNRS UMR3347, University Paris-Saclay
Career Start Year 2009
Number of shared co-authors 0
James M Barnes
Center for Bioengineering and Tissue Regeneration
Career Start Year 2007
Number of shared co-authors 0
Jerry S H Lee
University of Southern California
Career Start Year 2004
Number of shared co-authors 0
Shannon K Alford
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 1
Michael G Ozawa
Stanford University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Jose Javier Bravo-Cordero
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2004
Number of shared co-authors 1
Jalna Meens
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 0
Ivy X Chen
Massachusetts General Hospital
Career Start Year 2002
Number of shared co-authors 0
Tuomas Tammela
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Hon S Leong
University of Toronto
Career Start Year 2002
Number of shared co-authors 0
Chantal Pauli
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 0
Trevor D McKee
University Health Network
Career Start Year 2001
Number of shared co-authors 0
Christopher D Willey
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Joshua M Lang
19University of Wisconsin Carbone Cancer Center.
Career Start Year 2000
Number of shared co-authors 0
Alana L Welm
Huntsman Cancer Institute, University of Utah
Career Start Year 1999
Number of shared co-authors 0
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 0
Gabriele Bergers
VIB-Center for Cancer Biology
Career Start Year 1991
Number of shared co-authors 0
Roger Chammas
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 0
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 1
Valerie M Weaver
University of California san francisco
Career Start Year 1988
Number of shared co-authors 0
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Rakesh K Jain
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1978
Number of shared co-authors 0

Collaborators

Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Co-authored papers 9
Zhiyong Wang
Moores Cancer Center, University of California San Diego
Co-authored papers 8
Yusuke Goto
Chiba University Graduate School of Medicine
Co-authored papers 5
Alfredo A Molinolo
University of California
Co-authored papers 5
Michael M Allevato
University of Michigan Medical School.
Co-authored papers 4
Ezra E W Cohen
university of california san diego Health System
Co-authored papers 3
Joseph A Califano
University of California
Co-authored papers 3
Nadia Arang
Moores Cancer Center, University of California San Diego
Co-authored papers 2
Robert Saddawi-Konefka
Moores Cancer Center, University of California San Diego
Co-authored papers 2
Mizuo Ando
University of Tokyo
Co-authored papers 2
Pablo Tamayo
University of California San Diego
Co-authored papers 1
Kathleen M Fisch
Center for Computational Biology and Bioinformatics, University of California
Co-authored papers 1
Shuling Ren
Beijing Friendship Hospital, Capital Medical University
Co-authored papers 1
Sunil J Advani
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Juan L Callejas-Valera
Cancer Biology Research Center
Co-authored papers 1
Ana Velic
Interfaculty Institute for Cell Biology.
Co-authored papers 1
Guorong Xu
Chinese University of Hong Kong
Co-authored papers 1
Xingyu Wu
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Theresa Guo
Moores Cancer Center, University of California
Co-authored papers 1
Akihiro Sakai
Tokai University
Co-authored papers 1
Jennifer R Grandis
University of California san francisco
Co-authored papers 1
Alexander V Favorov
Johns Hopkins School of Medicine
Co-authored papers 1
Chao Liu
Xiangya Hospital, Central South University
Co-authored papers 1
Takahito Fukusumi
Osaka University Graduate School of Medicine
Co-authored papers 1
Jessica Santos
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Umamaheswar Duvvuri
University of Pittsburgh School of Medicine
Co-authored papers 1
Daria A Gaykalova
Institute for Genome Sciences, University of Maryland School of Medicine
Co-authored papers 1
Wayne M Koch
Johns Hopkins University School of Medicine
Co-authored papers 1
Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers 1
Sayed Sadat
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Release 1.2